Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
How oncologists respond to negative trials
FDA Withdrawals and Oncology Drug Use The U.S. Food and Drug Administration’s (FDA) accelerated approval…
Preventable paediatric cancer mortality surges in areas of armed conflict, exceeding rates in non-conflict regions
More than half of all paediatric cancer deaths worldwide occur in regions of armed conflict,…
Daily physical activity, even at light intensities, linked to lower cancer risk
In a prospective cohort study of more than 85,000 adults in the United Kingdom, researchers…
New explanation for how cancer drugs destroy BRCA1 and BRCA2 tumour cells
- Study identifies immune response that may stop breast cancer from spreading
- New technique to measure circulating tumour DNA in metastatic cancer may improve disease progression surveillance and patient outcomes
- New research identifies FAM20C as a critical protein kinase in cancer progression and disease mechanisms
UNSW’s rural medical school receives development approval
The federal government’s commitment of $21m to UNSW’s Biomedical Sciences Centre in Wagga Wagga will ensure more medical students are trained in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.